查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1595309

医药 B2B 电子商务市场：经营模式、产品类型、治疗领域、经销类型 - 2025-2030 年全球预测

Pharma B2B eCommerce Market by Business Model (B2B2B, B2B2C), Product Type (Over-the-Counter (OTC) Products, Prescription Drugs), Therapeutic Area, Distribution Type - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年医药B2B电商市场规模为281.1亿美元，预计2024年将达302.3亿美元，复合年增长率为7.70%，预计2030年将达472.7亿美元。

医药B2B电子商务市场范围涵盖医药产品的数位化购买和销售，特别是医院、诊所、药局和经销商等企业。随着数位转型的发展，这项市场需求源自于简化采购流程、提高成本效率和提高供应链透明度的需求。该领域的应用包括用于直接订购的数位平台、库存管理系统和增强的供应商协作。最终用途主要是医疗保健提供者、药品製造商和研究机构。主要成长要素包括医疗保健数位化的提高、慢性病数量迅速增加对医药中间体的需求增加，以及需要有效追踪和监控药品交易的监管合规性的提高。潜在的机会在于人工智慧 (AI) 支援的预测分析、透过先进的数位介面改善用户体验以及透过全球线上平台扩大覆盖范围。鼓励企业投资扩充性的电子商务解决方案以实现未来成长，遵守资料安全措施，并采用多通路参与策略来提高客户满意度。然而，严格的政府监管、网路安全风险和高昂的初始投资成本等限制和挑战构成了主要障碍。此外，传统采购方法的变革阻力和资料整合的复杂性是常见的障碍。研究和开发应专注于开发强大的区块链系统以确保交易透明度和安全性、用于客户协助的基于人工智慧的聊天机器人以及用于即时库存管理的物联网应用程式。市场是充满活力的，并因技术进步和监管变化而蓬勃发展，因此持续监控和适应这些变化以维持业务成功和竞争力非常重要。最终，医药B2B电子商务的发展能力将取决于其有效应对这些挑战、优化供应链以及利用未来新技术趋势的能力。

主要市场统计
基准年[2023] 281.1亿美元
预测年份 [2024] 302.3亿美元
预测年份 [2030] 472.7亿美元
复合年增长率（%） 7.70%

市场动态：揭示快速发展的医药 B2B 电子商务市场的关键市场洞察

供需的动态交互作用正在改变医药 B2B 电子商务市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 药局与医疗机构数位转型介绍
    • 采购管理改善采购流程并减少复杂的运输处理
    • 维持监管控制和可追溯性的需要
  • 市场限制因素
    • 电子商务平台与现有系统的复杂集成
  • 市场机会
    • 在开发个人化方法和改善客户体验方面快速成长
    • 加大投入提升医药B2B电商平台营运效率
  • 市场挑战
    • 仿冒品和品质问题

波特五力：驾驭医药 B2B 电子商务市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解医药B2B电子商务市场的外部影响

外部宏观环境因素对于塑造医药B2B电商市场的绩效动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解医药B2B电商市场竞争态势

医药 B2B 电子商务市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 医药 B2B 电子商务市场定位矩阵供应商绩效评估

FPNV定位矩阵是评估医药B2B电子商务市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议绘製 B2B 电子商务市场的成功之路

医药 B2B 电子商务市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 推动药房和医疗保健提供者的数位转型
      • 采购管理改善了采购流程并降低了运输流程的复杂性。
      • 需要维持目录有限的药品的监管控制和可追溯性。
    • 抑制因素
      • 电商平台与现有系统的复杂集成
    • 机会
      • 在开发个人化方法和改善客户体验方面快速成长
      • 加大投入提升医药B2B电商平台营运效率
    • 任务
      • 药品假冒和品质问题
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 医药B2B电子商务市场：依经营模式

  • B2B2B
  • B2B2C

第七章 医药B2B电子商务市场：依产品类型

  • 非处方药 (OTC)
  • 处方药
    • 糖尿病管理
    • 专门护理
    • 疫苗

第八章依治疗领域分類的医药B2B电子商务市场

  • 心血管
  • 皮肤科
  • 胃肠病学
  • 感染疾病
  • 神经病学
  • 肿瘤学
  • 呼吸系统

第九章以配送类型分類的医药B2B电子商务市场

  • 由经销商/批发商拥有的数位电子商务
  • 药品製造商自有的数位电子商务

第十章 美洲医药B2B电商市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章 亚太医药B2B电子商务市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东、非洲医药B2B电商市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Udaan 宣布为药局提供“4x4 送货服务”
    • Saveo 筹集 450 万美元以简化 B2B 药品供应链
    • 亚洲医疗保健集团开发关键高科技平台来战胜 COVID-19
  • 战略分析和建议

公司名单

  • Amazon.com, Inc.
  • AmerisourceBergen Corporation
  • Ayro Retail Solutions Pvt. Ltd
  • Becton, Dickinson & Company
  • Biddano Pvt Ltd.
  • Cardinal Health, Inc.
  • Cloudfy Ltd.
  • Corevist, Inc.
  • Divante SA
  • Entersoft SA
  • Eurofins Scientific
  • EuroPlux
  • GXgate
  • Henry Schein, Inc.
  • hystrix medical AG
  • Invertus
  • Mckesson Corporation
  • Medcombo by Behmpat Producciones SL
  • Medideals Resources LLP
  • Merck KGaA
  • Ochre Media Pvt Ltd
  • Oro, Inc.
  • Pharma Vends by Hivends Info Solutions Pvt. Ltd
  • Pharmaflair
  • Pharmaoffer
  • PHARMATRADZ
  • Piegon Media Pvt. Ltd.
  • PipelinePharma
  • Remedial Health Solutions Limited
  • Sandoz by Novartis AG
  • Thermo Fisher Scientific, Inc.
  • TrueCommerce Inc.
  • Trxade, Health Inc.
  • Wizarma Healthcare Private Limited
  • Yaoshibang
Product Code: MRR-2F11EB639CB7

The Pharma B2B eCommerce Market was valued at USD 28.11 billion in 2023, expected to reach USD 30.23 billion in 2024, and is projected to grow at a CAGR of 7.70%, to USD 47.27 billion by 2030.

The Pharma B2B eCommerce market scope encompasses the digital buying and selling of pharmaceutical products, especially targeting businesses such as hospitals, clinics, pharmacies, and distributors. With the increasing digital shift, the necessity for this market stems from the need for streamlined procurement processes, cost efficiencies, and enhanced supply chain transparency. Applications within this domain include digital platforms for direct ordering, inventory management systems, and enhanced vendor collaboration. End-use scope primarily revolves around serving healthcare providers, pharmaceutical manufacturers, and research institutions. Key growth influencers include the rise in healthcare digitization, growing demand for pharmaceutical intermediates due to the proliferation of chronic diseases, and an increase in regulatory compliances that necessitate efficient tracking and monitoring of pharmaceutical transactions. Potential opportunities lie in leveraging Artificial Intelligence (AI) for predictive analytics, enhancing user experience with advanced digital interfaces, and expanding reach through global online platforms. Companies are recommended to invest in scalable eCommerce solutions that accommodate future growth, adhere to data security measures, and incorporate multi-channel engagement strategies to heighten customer satisfaction. However, limitations and challenges such as stringent governmental regulations, cybersecurity risks, and high initial investment costs pose significant hurdles. Moreover, resistance to change from traditional procurement methods and data integration complexities are prevalent barriers. Innovation and research should focus on developing robust blockchain systems for transparency and security in transactions, AI-based chatbots for customer assistance, and IoT applications for real-time inventory management. The market is dynamic, thriving on technological advancements and regulatory shifts, so consistent monitoring and adaptation to these changes will be crucial for sustained business success and competitiveness. Ultimately, the forward momentum of Pharma B2B eCommerce hinges on effectively addressing these challenges and capitalizing on emerging technology trends to optimize and future-proof supply chains.

KEY MARKET STATISTICS
Base Year [2023] USD 28.11 billion
Estimated Year [2024] USD 30.23 billion
Forecast Year [2030] USD 47.27 billion
CAGR (%) 7.70%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pharma B2B eCommerce Market

The Pharma B2B eCommerce Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Embracing digital transformation in pharmacies and healthcare providers
    • Improve the procurement process with purchase controls and reduce the complexity of carriage handling
    • Need to maintain regulatory control and traceability in pharma with restricted catalogs
  • Market Restraints
    • Complex integration of eCommerce platforms with the existing systems
  • Market Opportunities
    • Rapid growth in developing personalized approaches and improving the customer experiences
    • Increasing investment to improve the operational efficiencies of pharma B2B eCommerce platforms
  • Market Challenges
    • Issues associated with the counterfeit and quality concerns of the pharma products

Porter's Five Forces: A Strategic Tool for Navigating the Pharma B2B eCommerce Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pharma B2B eCommerce Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pharma B2B eCommerce Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pharma B2B eCommerce Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pharma B2B eCommerce Market

A detailed market share analysis in the Pharma B2B eCommerce Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pharma B2B eCommerce Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pharma B2B eCommerce Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pharma B2B eCommerce Market

A strategic analysis of the Pharma B2B eCommerce Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pharma B2B eCommerce Market, highlighting leading vendors and their innovative profiles. These include Amazon.com, Inc., AmerisourceBergen Corporation, Ayro Retail Solutions Pvt. Ltd, Becton, Dickinson & Company, Biddano Pvt Ltd., Cardinal Health, Inc., Cloudfy Ltd., Corevist, Inc., Divante S.A., Entersoft SA, Eurofins Scientific, EuroPlux, GXgate, Henry Schein, Inc., hystrix medical AG, Invertus, Mckesson Corporation, Medcombo by Behmpat Producciones S.L, Medideals Resources LLP, Merck KGaA, Ochre Media Pvt Ltd, Oro, Inc., Pharma Vends by Hivends Info Solutions Pvt. Ltd, Pharmaflair, Pharmaoffer, PHARMATRADZ, Piegon Media Pvt. Ltd., PipelinePharma, Remedial Health Solutions Limited, Sandoz by Novartis AG, Thermo Fisher Scientific, Inc., TrueCommerce Inc., Trxade, Health Inc., Wizarma Healthcare Private Limited, and Yaoshibang.

Market Segmentation & Coverage

This research report categorizes the Pharma B2B eCommerce Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Business Model, market is studied across B2B2B and B2B2C.
  • Based on Product Type, market is studied across Over-the-Counter (OTC) Products and Prescription Drugs. The Prescription Drugs is further studied across Diabetes Management, Specialty Care, and Vaccines.
  • Based on Therapeutic Area, market is studied across Cardiovascular, Dermatology, Gastroenterology, Infectious Diseases, Neurology, Oncology, and Respiratory.
  • Based on Distribution Type, market is studied across Distributor/Wholesaler-Owned Digital eCommerce and Pharmaceutical Manufacturer-Owned Digital eCommerce.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Embracing digital transformation in pharmacies and healthcare providers
      • 5.1.1.2. Improve the procurement process with purchase controls and reduce the complexity of carriage handling
      • 5.1.1.3. Need to maintain regulatory control and traceability in pharma with restricted catalogs
    • 5.1.2. Restraints
      • 5.1.2.1. Complex integration of eCommerce platforms with the existing systems
    • 5.1.3. Opportunities
      • 5.1.3.1. Rapid growth in developing personalized approaches and improving the customer experiences
      • 5.1.3.2. Increasing investment to improve the operational efficiencies of pharma B2B eCommerce platforms
    • 5.1.4. Challenges
      • 5.1.4.1. Issues associated with the counterfeit and quality concerns of the pharma products
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pharma B2B eCommerce Market, by Business Model

  • 6.1. Introduction
  • 6.2. B2B2B
  • 6.3. B2B2C

7. Pharma B2B eCommerce Market, by Product Type

  • 7.1. Introduction
  • 7.2. Over-the-Counter (OTC) Products
  • 7.3. Prescription Drugs
    • 7.3.1. Diabetes Management
    • 7.3.2. Specialty Care
    • 7.3.3. Vaccines

8. Pharma B2B eCommerce Market, by Therapeutic Area

  • 8.1. Introduction
  • 8.2. Cardiovascular
  • 8.3. Dermatology
  • 8.4. Gastroenterology
  • 8.5. Infectious Diseases
  • 8.6. Neurology
  • 8.7. Oncology
  • 8.8. Respiratory

9. Pharma B2B eCommerce Market, by Distribution Type

  • 9.1. Introduction
  • 9.2. Distributor/Wholesaler-Owned Digital eCommerce
  • 9.3. Pharmaceutical Manufacturer-Owned Digital eCommerce

10. Americas Pharma B2B eCommerce Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Pharma B2B eCommerce Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Pharma B2B eCommerce Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Udaan Announces '4x4 Delivery Service' For Pharmacies
    • 13.3.2. Saveo Raises USD 4.5 Mn To Streamline B2B Pharma Supply Chain
    • 13.3.3. Asian Healthcare Group Develops Vital High-Tech Platform, Beating Back COVID-19
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Amazon.com, Inc.
  • 2. AmerisourceBergen Corporation
  • 3. Ayro Retail Solutions Pvt. Ltd
  • 4. Becton, Dickinson & Company
  • 5. Biddano Pvt Ltd.
  • 6. Cardinal Health, Inc.
  • 7. Cloudfy Ltd.
  • 8. Corevist, Inc.
  • 9. Divante S.A.
  • 10. Entersoft SA
  • 11. Eurofins Scientific
  • 12. EuroPlux
  • 13. GXgate
  • 14. Henry Schein, Inc.
  • 15. hystrix medical AG
  • 16. Invertus
  • 17. Mckesson Corporation
  • 18. Medcombo by Behmpat Producciones S.L
  • 19. Medideals Resources LLP
  • 20. Merck KGaA
  • 21. Ochre Media Pvt Ltd
  • 22. Oro, Inc.
  • 23. Pharma Vends by Hivends Info Solutions Pvt. Ltd
  • 24. Pharmaflair
  • 25. Pharmaoffer
  • 26. PHARMATRADZ
  • 27. Piegon Media Pvt. Ltd.
  • 28. PipelinePharma
  • 29. Remedial Health Solutions Limited
  • 30. Sandoz by Novartis AG
  • 31. Thermo Fisher Scientific, Inc.
  • 32. TrueCommerce Inc.
  • 33. Trxade, Health Inc.
  • 34. Wizarma Healthcare Private Limited
  • 35. Yaoshibang

LIST OF FIGURES

  • FIGURE 1. PHARMA B2B ECOMMERCE MARKET RESEARCH PROCESS
  • FIGURE 2. PHARMA B2B ECOMMERCE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS PHARMA B2B ECOMMERCE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS PHARMA B2B ECOMMERCE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES PHARMA B2B ECOMMERCE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES PHARMA B2B ECOMMERCE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC PHARMA B2B ECOMMERCE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC PHARMA B2B ECOMMERCE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PHARMA B2B ECOMMERCE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PHARMA B2B ECOMMERCE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. PHARMA B2B ECOMMERCE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. PHARMA B2B ECOMMERCE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PHARMA B2B ECOMMERCE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PHARMA B2B ECOMMERCE MARKET DYNAMICS
  • TABLE 7. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY B2B2B, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY B2B2C, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY OVER-THE-COUNTER (OTC) PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY DIABETES MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY SPECIALTY CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY RESPIRATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTOR/WHOLESALER-OWNED DIGITAL ECOMMERCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL PHARMA B2B ECOMMERCE MARKET SIZE, BY PHARMACEUTICAL MANUFACTURER-OWNED DIGITAL ECOMMERCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS PHARMA B2B ECOMMERCE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES PHARMA B2B ECOMMERCE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC PHARMA B2B ECOMMERCE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA PHARMA B2B ECOMMERCE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM PHARMA B2B ECOMMERCE MARKET SIZE, BY BUSINESS MODEL, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM PHARMA B2B ECOMMERCE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM PHARMA B2B ECOMMERCE MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM PHARMA B2B ECOMMERCE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM PHARMA B2B ECOMMERCE MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. PHARMA B2B ECOMMERCE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 238. PHARMA B2B ECOMMERCE MARKET, FPNV POSITIONING MATRIX, 2023